TSE •
Healthcare •
Biotechnology •
Quote as of 09/11/2026
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeTSE
Market Capitalization4,324.41 mln
Float1.54 mln
Earnings Date05/14/2025
EPS
49.13
Exceptional
P / E
16.87
Moderately valued
Piotroski F-Score
4
/ 9
Borderline
Beneish M-Score
-2.76
Likely reliable
Relative Strength
60
/ 100
Outperforming
Debt / Equity
0.31
Low leverage
Business Description
Kohjin Bio Co. Ltd., headquartered in Sakado, Japan, develops and sells a broad range of biological products including cell culture media, microbiology testing materials, in vitro diagnostic tools, and cosmetics. The company serves research and clinical markets with solutions for human and industrial cell cultivation, microbial testing, and diagnostic assay kits, as well as human blood serum and plasma products. It also provides laboratory animal services, medical equipment, and handles the import and export of related products and raw materials. Originally founded in 1981 as Kohjin Co. Ltd., the company adopted its current name in 1989.
